| Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non … L Jørgensen, AS Paludan-Müller, DRT Laursen, J Savović, I Boutron, ... Systematic reviews 5 (1), 80, 2016 | 346* | 2016 |
| Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study H Moustgaard, GL Clayton, HE Jones, I Boutron, L Jørgensen, ... bmj 368, 2020 | 273 | 2020 |
| Randomized clinical trials with run-in periods: frequency, characteristics and reporting DRT Laursen, AS Paludan-Müller, A Hróbjartsson Clinical Epidemiology 11, 169, 2019 | 63 | 2019 |
| Mechanisms and direction of allocation bias in randomised clinical trials A Paludan-Müller, DRT Laursen, A Hróbjartsson BMC medical research methodology 16 (1), 133, 2016 | 25 | 2016 |
| Active placebo versus standard placebo control interventions in pharmacological randomised trials DRT Laursen, C Hansen, AS Paludan-Müller, A Hróbjartsson Cochrane Database of Systematic Reviews, 2020 | 16 | 2020 |
| Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo DRT Laursen, CH Nejstgaard, E Bjørkedal, AD Frost, MR Hansen, ... Cochrane Database of Systematic Reviews, 2023 | 10 | 2023 |
| Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta‐epidemiological studies CH Nejstgaard, DRT Laursen, A Lundh, A Hróbjartsson Research Synthesis Methods 14 (2), 144-155, 2023 | 7 | 2023 |
| Critical reading of systematic review articles DRT Laursen, S Brorson, A Lundh, AM Møller, CH Nejstgaard, ... Ugeskrift for Laeger 186 (13), V09230616-V09230616, 2024 | 2* | 2024 |
| Combining meta‐epidemiological study datasets on commercial funding of randomised clinical trials: Database, methods, and descriptive results of the COMFIT study CH Nejstgaard, A Lundh, S Abdi, G Clayton, MHA Gelle, DRT Laursen, ... Research Synthesis Methods 13 (2), 214-228, 2022 | 1 | 2022 |
| The impact of active placebo control groups on estimated intervention effects in pharmacological randomized trials: a meta-epidemiological study DRT Laursen, M Ivosevic, CH Nejstgaard, AH Eiset, M Elkjær, E Faltinsen, ... Abstracts accepted for the 2nd Global Evidence Summit, Prague, Czech …, 2024 | | 2024 |
| Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project JD Wilkinson, C Heal, G Antoniou, E Flemyng, L Ahnström, A Alteri, ... medRxiv, 2024.11. 25.24316905, 2024 | | 2024 |
| Impact of active placebo controls on estimated drug effects in randomised trials DRT Laursen, CH Nejstgaard, E Bjørkedal, AD Frost, MR Hansen, ... Abstracts accepted for the 27th Cochrane Colloquium, London, UK 2023 (1 Suppl 1), 2023 | | 2023 |
| Critically Appraised Topic (CAT) CH Nejstgaard, DRT Laursen, L Østengaard Evidensbaseret medicin og klinisk forskningsmetode, 2022 | | 2022 |
| Placebo DRT Laursen, A Hróbjartsson Evidensbaseret medicin og klinisk forskningsmetode, 455-474, 2022 | | 2022 |
| Active placebo vs standard placebo control interventions in pharmacological randomised trials: a meta-epidemiological study: Study registration and protocol DRT Laursen, E Faltinsen, AS Paludan-Müller, CH Nejstgaard, ... | | 2021 |
| Active placebo versus standard placebo control interventions in pharmacological randomised trials: a systematic review DRT Laursen, AS Paludan-Müller, A Hrõbjartsson Abstracts of the 26th Cochrane Colloquium, Santiago, Chile 2020 (1 Suppl 1), 307, 2020 | | 2020 |
Asger Paludan-MüllerPost.doc, Centre for Evidence-Based Medicine and Cochrane DenmarkVerified email at nhta.com
